Andrew Jackson

Andrew Jackson has extensive experience in financial leadership, primarily serving as Chief Financial Officer for multiple companies, including Calidi Biotherapeutics, Eterna Therapeutics, Ra Medical Systems, and AltheaDx, where Jackson also held the role of Interim Chief Executive Officer from August 2019 to March 2020. In addition to these positions, Jackson operates as a self-employed Fractional Chief Financial Officer. Academic qualifications include an MBA in Finance from San Diego State University and a Bachelor’s Degree in Accounting from the University of Minnesota.